Skip to main content
 

BioIntelliSense Recognized as the “Best Overall Medical Device Company” for 2023 in the 7th Annual MedTech Breakthrough Awards Program

BioIntelliSense Recognized as the “Best Overall Medical Device Company” for 2023 in the 7th Annual MedTech Breakthrough Awards Program

MedTech Breakthrough selects BioIntelliSense with its BioButton® multi-parameter, medical grade wearable device and advanced clinical intelligence solutions as the “2023 Best Overall Medical Device Company.” BioIntelliSense continues to deliver breakthrough clinical intelligence solutions for scalable continuous patient monitoring and tech-enabled care.

Read more here

More News

  • WELL Health Partners with AliveCor to Bring AI-Powered Cardiac Monitoring and Cardiologist Oversight to Canadians

  • Noah Labs Obtains FDA Breakthrough Device Designation for its AI-Powered Voice Diagnostic for Heart Failure

  • Tabia Health Announces Its AI-Powered Care Orchestration Platform is Now a Qualified Solution on Mayo Clinic Platform, Enabling Care Workflow Transformation.